Danaher - 48 Year Stock Price History | DHR
Historical daily share price chart and data for Danaher since 1978 adjusted for splits and dividends. The latest closing stock price for Danaher as of January 16, 2026 is 235.99.
- The all-time high Danaher stock closing price was 288.81 on September 03, 2021.
- The Danaher 52-week high stock price is 258.23, which is 9.4% above the current share price.
- The Danaher 52-week low stock price is 171.00, which is 27.5% below the current share price.
- The average Danaher stock price for the last 52 weeks is 207.66.
| Danaher Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 236.3345 | 230.4000 | 239.8900 | 230.4000 | 235.9900 | 3.09% |
| 2025 | 206.9280 | 228.3750 | 249.0260 | 173.8140 | 228.9200 | 0.35% |
| 2024 | 249.6250 | 232.3220 | 278.4100 | 222.2190 | 228.1170 | -0.35% |
| 2023 | 215.8395 | 229.0300 | 241.8930 | 182.9660 | 228.9080 | -1.24% |
| 2022 | 235.2114 | 274.6960 | 274.6960 | 206.4550 | 231.7810 | -19.02% |
| 2021 | 238.7393 | 193.6020 | 288.8110 | 184.1920 | 286.2230 | 48.57% |
| 2020 | 160.5704 | 133.9670 | 212.7080 | 104.8430 | 192.6570 | 45.34% |
| 2019 | 114.9432 | 86.3845 | 132.5590 | 83.9091 | 132.5590 | 49.55% |
| 2018 | 86.5626 | 78.9536 | 94.0041 | 78.7144 | 88.6365 | 11.80% |
| 2017 | 73.0911 | 66.8556 | 80.6946 | 66.8556 | 79.2781 | 20.01% |
| 2016 | 52.6601 | 37.5801 | 69.2307 | 34.2639 | 66.0579 | 73.51% |
| 2015 | 35.8581 | 34.8376 | 39.8470 | 33.3294 | 38.0720 | 9.30% |
| 2014 | 31.3470 | 30.9137 | 35.3823 | 29.1063 | 34.8336 | 11.59% |
| 2013 | 26.5981 | 23.2081 | 31.2170 | 23.2081 | 31.2170 | 38.31% |
| 2012 | 21.4245 | 19.5255 | 22.9349 | 19.4772 | 22.5701 | 19.06% |
| 2011 | 19.6787 | 18.9825 | 22.4426 | 16.2808 | 18.9573 | -0.09% |
| 2010 | 16.1258 | 15.0856 | 19.0468 | 14.0819 | 18.9744 | 25.69% |
| 2009 | 12.4268 | 11.5794 | 15.2682 | 9.6221 | 15.0957 | 33.11% |
| 2008 | 14.4102 | 17.2330 | 17.3810 | 9.9052 | 11.3410 | -35.37% |
| 2007 | 15.3554 | 14.3095 | 17.7170 | 13.9559 | 17.5471 | 21.29% |
| 2006 | 12.9848 | 11.2423 | 14.9703 | 10.8314 | 14.4672 | 30.02% |
| 2005 | 10.7381 | 11.2019 | 11.5792 | 9.6766 | 11.1266 | -2.71% |
| 2004 | 9.9390 | 9.0263 | 11.6790 | 8.7546 | 11.4370 | 25.29% |
| 2003 | 7.1993 | 6.7084 | 9.1486 | 6.0078 | 9.1287 | 39.81% |
| 2002 | 6.3313 | 5.9843 | 7.4780 | 5.2868 | 6.5295 | 9.09% |
| 2001 | 5.7969 | 6.5903 | 6.7080 | 4.5151 | 5.9853 | -11.67% |
| 2000 | 5.0987 | 4.6020 | 6.8071 | 3.6742 | 6.7761 | 41.90% |
| 1999 | 5.4214 | 5.2700 | 6.7795 | 4.2666 | 4.7751 | -11.06% |
| 1998 | 3.7764 | 3.0850 | 5.3689 | 2.9029 | 5.3689 | 72.31% |
| 1997 | 2.5293 | 2.2540 | 3.1467 | 1.9533 | 3.1158 | 35.64% |
| 1996 | 1.9285 | 1.5297 | 2.2971 | 1.4498 | 2.2971 | 47.21% |
| 1995 | 1.4774 | 1.2273 | 1.6752 | 1.1674 | 1.5604 | 24.71% |
| 1994 | 1.0175 | 0.9102 | 1.2662 | 0.8655 | 1.2512 | 37.46% |
| 1993 | 0.7602 | 0.6244 | 0.9304 | 0.5798 | 0.9102 | 47.16% |
| 1992 | 0.5572 | 0.4787 | 0.6363 | 0.4728 | 0.6185 | 28.40% |
| 1991 | 0.4746 | 0.3865 | 0.5531 | 0.3806 | 0.4817 | 26.56% |
| 1990 | 0.4111 | 0.3687 | 0.5471 | 0.3330 | 0.3806 | 4.94% |
| 1989 | 0.3837 | 0.3360 | 0.4311 | 0.3152 | 0.3627 | 7.95% |
| 1988 | 0.3412 | 0.2141 | 0.4757 | 0.1784 | 0.3360 | 66.17% |
| 1987 | 0.2636 | 0.1502 | 0.3955 | 0.1502 | 0.2022 | 37.36% |
| 1986 | 0.1265 | 0.0981 | 0.1546 | 0.0848 | 0.1472 | 57.10% |
| 1985 | 0.0936 | 0.0818 | 0.1130 | 0.0803 | 0.0937 | 12.62% |
| 1984 | 0.0749 | 0.0565 | 0.0907 | 0.0565 | 0.0832 | 55.51% |
| 1983 | 0.0448 | 0.0327 | 0.0565 | 0.0327 | 0.0535 | 80.13% |
| 1982 | 0.0319 | 0.0401 | 0.0431 | 0.0253 | 0.0297 | -28.61% |
| 1981 | 0.0544 | 0.0550 | 0.0728 | 0.0342 | 0.0416 | -17.79% |
| 1980 | 0.0478 | 0.0535 | 0.0639 | 0.0327 | 0.0506 | -8.00% |
| 1979 | 0.0568 | 0.0431 | 0.0728 | 0.0416 | 0.0550 | 27.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $166.692B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |